Association of MTHFR A1298C polymorphism (but not of MTHFR C677T) with elevated homocysteine levels and placental vasculopathies

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 5, 2011, Pages 374-378

  Klai, Sarra ^a   Fekih Mrissa, Najiba ^a   El Housaini, Sonia ^b   Kaabechi, Naziha ^c   Nsiri, Brahim ^a   Rachdi, Radhouen ^c   Gritli, Nasredine ^a  

^a MILITARY HOSPITAL OF TUNIS   (Tunisia)

^b Military Hospital   (Tunisia)

^c LA RABTA HOSPITAL   (Tunisia)

Author keywords

elevated homocysteine levels; MTHFR A1298C mutation; MTHFR C677T mutation; placental vasculopathies

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; SOLUTIO PLACENTAE; VASCULAR DISEASE;

CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PLACENTA; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; VASCULAR DISEASES;

EID: 79960700820     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328344f80f     Document Type: Article

References (33)

1. Jody L. Thrombophilia and pregnancy complications. Am J Obstet Gynecol 2004; 191:412-424
2. Refsum H, Ueland P, Nygård O, Vollset S. Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49:31-62 (Pubitemid 28197439)
3. Aubard Y, Darodes N, Cantaloube M, Aubard V, Diallo D, Teissier MP. Hyperhomocysteinemia and pregnancy: a dangerous association. J Gynecol Obstet Biol Reprod 2000; 29:363-372 (Pubitemid 30415211)
4. Slawomir S. Hyperhomocysteinemia and pregnancy complications. Ginekol Pol 2004; 75:317-325
5. Henrik Z, Antonio C, Armando D, Mona P, Lars R, Kaj B. No association between the MTHFR A1298C and transcobalamin C776G genetic polymorphisms and hyperhomocysteinemia in thrombotic disease. Thromb Res 2002; 108:127-131
6. Eyal YA, Banan M, Ariel M, Anat B, Shmuel G, Dan V, et al. Fetal inherited thrombophilias influence the severity of preeclampsia, IUGR and placental abruption. Eur J Obstet Gynecol Reprod Biol 2004; 113:31-35
7. Yves A, Nicole D, Muriel C. Hyperhomocysteinemia and pregnancy review of our present understanding and therapeutic implications. Eur J Obstet Gynecol Reprod Biol 2000; 93:157-165
8. Clark R, Daily L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular diseases. N Engl J Med 1991; 324:1149-1155
9. Ray JG, Laskin CA. Folic acid and homocysteine metabolic defects and the risk of placental abruption, preeclampsia and spontaneous pregnancy losses: a systematic review. Placenta 1999; 20:519-529 (Pubitemid 29391295)
10. Mark CW, Graeme NS, Sherry LP, Erin JK, Peter RG. Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol 1999; 180:660-664
11. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161:1200-1204 (Pubitemid 20007682)
12. Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of preeclampsia? Lancet 1999; 354:788-789 (Pubitemid 29415578)
13. Powers RW, Evans RW, Majors AK, Ojimbba JI, Ness RB, Crombleholme WR, et al. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 1998; 179:1605-1611 (Pubitemid 29028409)
14. Dekker GA, DeVries JIP, Doelitzch PM, Huijgens PC, Von Blomberg BME, Jakobs C. Underlying disorders associated with severe early onset preeeclampsia. Am J Obstet Gynecol 1995; 173:1042-1048
15. Rajkovic A, Catalano PM, Malinow R. Elevated homocysteine levels with preeclampsia. Obstet Gynecol 1997; 90:168-171
16. Pabinger I. Thrombophilia and its impact on pregnancy. Thromb Res 2009; 123 (Suppl 3):S16-S21
17. Kutteh WH, Jaslow CR, Ke RW. Elevated homocysteine levels in women with recurrent pregnancy losses are associated with A1298C mutations of methylenetetrahydrofolate reductase in the absence of C677T mutations. Fertil Steril 2006; 86 (Suppl.):2
18. Goddijn-Wessel TA, Wouters MG, Van De Molen EF, Spuijbroek MD, Steegers-Theunissen RP, Blom HJ, et al. Hyperhomocysteinaemia: a risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol 1996; 66:23-29 (Pubitemid 26150043)
19. De Vries JLP, Dekker GA, Huijgens PC, Jakobs C, Blomberg BME, Van Geijn HP. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies. Br J Obstet Gynaecol 1997; 104:1248-1254 (Pubitemid 27485491)
20. Leeda M, Riyazi N, De Vries JIP, Jakobs C, Van Geijn HP, Dekker GA. Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. Am J Obstet Gynecol 1998; 179:135-139 (Pubitemid 28394486)
21. Mtiraoui N, Zammiti W, Ghazouani L, Jmili Braham N, Saidi S, Finan RR, et al. Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses. Reproduction 2006; 131:395-401 (Pubitemid 43273699)
22. Kutteh WH, Park VM, Deitcher SR. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss.Fertil Steril 1997; 1:1048-1053 (Pubitemid 29252494)
23. Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod 2002; 17:1633-1637 (Pubitemid 34661820)
24. Gabriel S, Charlotte L, Renate H, Hein J. Combined heterozygotity for methylenetetrahydrofolate reductase MTHFR mutations C677T and A1298C is associated with abruption placenta but not with intrauterine growth restriction. Eur J Obstet Gynaecol Reprod Biol 2001; 97:174-177
25. Ester J, Leeak K, Sari T, Eeva Liisa R, Seppo H, Kari P, et al. C677T polymorphism is not associated with placental abruption or preeclampsia in Finnish women. Hypertens Pregnancy 2004; 25:73-80
26. Eha N, Grethe S, Helga R, Per MU, Stein EV. Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: The Hordaland Homocysteine Study. Am J Med 2004; 117:26-31
27. Martinelli P, Grandone E, Colaizzo D, Paladini D, Sciannama N, Margaglione M, Minno GD. Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica 2001; 86:428-431 (Pubitemid 32428505)
28. Kaiser T, Brennecke SP, Moses EK. C677T methylenetetrahydrofolate reductase polymorphism is not a risk factor for pre eclampsia/eclampsia among Australian women. Hum Hered 2001; 51:20-22
29. Lachmeijer AM, Arngrimsson R, Bastians WJ, Pals G, Ten LP, de Vries JI. Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamin status in women with a history of preeclampsia. Am J Obstet Gynecol 2001; 184:394-402 (Pubitemid 32206990)
30. Zusterzeel PLM, Visser W, Blom HJ, Peters WH, Heil SG, Steegers EA. Methylenetetrahydrofolate reductase polymorphisms in preeclampsia and the HELLP syndrome. Hypertens Pregnancy 2000; 19:299-307
31. Robert WP, Michael SD, Marcia JG, James MR. The 677 C-T methylenetetrahydrofolate reductase mutation does not predict increased maternal homocysteine during pregnancy. Obstet Gynecol 2003; 101:762-766
32. Kutteh WH, Jaslow CR, Ke RW. Elevated homocysteine levels in women with recurrent pregnancy loss (RPL) are associated with A1298C mutations of methylenetetrahydrofolate reductase (MTHFR) in the absence of C677T mutations. Fertil Steril 2006; 86:S472-S473
33. Jitender K, Swapan KD, Priyanka S. Homocysteine levels are associated with MTHFR A1298C polymorphism in Indian population. J Hum Genet 2005; 50:656-663